产品简要
公司名称 :
伯乐(Bio-Rad)公司
其他品牌 :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
产品类型 :
抗体
产品名称 :
小鼠抗AKT1
目录 :
VMA00253
规格 :
100微升
价格 :
314美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
OTI4C11
反应物种 :
人类, 小鼠, 大鼠
应用 :
免疫印迹
更多信息或购买 :
图像
图像 1 :
伯乐(Bio-Rad)公司 VMA00253 图像 1
Western blot analysis of whole cell lysates probed with AKT1 antibody followed by detection with HRP conjugated Goat anti Mouse IgG (1/10,000, STAR207P ) and visualized on the ChemiDoc MP with 19 second exposure. Arrow points to AKT1 (molecular weight 60 kDa)
产品信息
EntityType :
PrecisionAb™ Monoclonal
EntityCategory :
抗体
ProductCode :
VMA00253
描述 :
MOUSE抗AKT1
特异性 :
AKT1
目标物种 :
人类
宿主 :
小鼠
格式 :
纯化
Isotypes :
IgG1
应用 :
免疫印迹
ApplicationTypes :
西方墨点法
CrossReactivities :
小鼠, 大鼠
克隆 :
OTI4C11
规格 :
100微升
QuantityValue :
100
QuantityType :
微升
GOAccessions :
GO:0005886, GO:0000060, GO:0005829, GO:0004674, GO:0005524, GO:0005547, GO:0005654, GO:0005978, GO:0006417, GO:0006469, GO:0006809, GO:0006924, GO:0007186, GO:0008286, GO:0008629, GO:0008633, GO:0042802, GO:0009408, GO:0010748, GO:0010975, GO:0016071, GO:0046326, GO:0046889, GO:0019899, GO:0018105, GO:0048015, GO:0030168, GO:0030235, GO:0030307, GO:0031018, GO:0031295, GO:0031659, GO:0031999, GO:0034405, GO:0043325, GO:0045429, GO:0045600, GO:0045725, GO:0046777, GO:0048009, GO:0048011, GO:0051000, GO:0070141, GO:0090004
GOTerms :
activated T cell apoptosis, activation of cell growth, activation of fat cell differentiation, activation of glucose import, activation of glycogen biosynthetic process, activation of lipid biosynthetic process, activation of nitric oxide biosynthetic process, activation of nitric-oxide synthase activity, activation-induced cell death of T lymphocytes, activation-induced cell death of T-cells, activation-induced cell death of T-lymphocytes, AICD, A-kinase activity, antigen-driven apoptosis, AP50 kinase activity, ATP:protein phosphotransferase (non-specific) activity, ATP-protein transphosphorylase activity, atypical PKC activity, atypical protein kinase C activity, bacterial inner membrane, betaIIPKC, blood coagulation, platelet activation, calcium/phospholipid-dependent protein kinase activity, casein kinase (phosphorylating) activity, cell membrane, cytidine 3',5'-cyclic monophosphate-responsive protein kinase activity, cytoplasmic membrane, daf-2 receptor signaling pathway, down regulation of fatty acid beta-oxidation, down regulation of protein kinase activity, down-regulation of fatty acid beta-oxidation, downregulation of fatty acid beta-oxidation, downregulation of protein kinase activity, down-regulation of protein kinase activity, dsk1, epsilon PKC, G protein coupled receptor protein signaling pathway, G protein coupled receptor protein signalling pathway, G1/S-specific activation of cyclin-dependent protein kinase activity, G1/S-specific positive regulation of cyclin-dependent protein kinase activity, G1/S-specific stimulation of cyclin-dependent protein kinase activity, G1/S-specific up regulation of cyclin-dependent protein kinase activity, G1/S-specific up-regulation of cyclin-dependent protein kinase activity, G1/S-specific upregulation of cyclin-dependent protein kinase activity, galactosyltransferase-associated kinase activity, glycogen anabolism, glycogen biosynthesis, glycogen formation, glycogen synthase a kinase activity, glycogen synthase kinase 3 activity, glycogen synthase kinase activity, glycogen synthesis, GO:0004695, GO:0004696, GO:0004700, GO:0005904, GO:0006445, GO:0006951, GPCR protein signaling pathway, GPCR protein signalling pathway, G-protein coupled receptor protein signal transduction, G-protein coupled receptor protein signalling pathway, G-protein-coupled receptor protein signaling pathway, G-protein-coupled receptor protein signalling pathway, HIPK2, Hpr kinase activity, hydroxyalkyl-protein kinase activity, IGF receptor signaling pathway, IGF receptor signalling pathway, induction of pro-apoptotic gene products, inhibition of fatty acid beta-oxidation, inhibition of protein kinase activity, inner endospore membrane, inositol phospholipid-mediated signaling, insulin receptor signalling pathway, isoform-specific homophilic binding, juxtamembrane, M phase-specific cdc2 kinase activity, MAPK, mitogen-activated protein kinase activity, mitogen-activated S6 kinase activity, mRNA metabolism, nerve growth factor receptor signalling pathway, NGF receptor signaling pathway, NGF receptor signalling pathway, nitric oxide anabolism, nitric oxide biosynthesis, nitric oxide formation, nitric oxide synthase regulator activity, nitric oxide synthesis, nitric-oxide synthase activator, non-specific serine/threonine protein kinase activity, NOS activator, p82 kinase activity, phosphatidylinositol-mediated signalling, phosphoinositide-mediated signaling, phosphoinositide-mediated signalling, phosphorylase B kinase kinase activity, PIP3 binding, PKA, PKC, plasma membrane lipid bilayer, plasmalemma, positive regulation of adipocyte cell differentiation, positive regulation of adipocyte differentiation, positive regulation of cyclin-dependent protein kinase activity during G1/S, positive regulation of establishment of protein localisation in plasma membrane, positive regulation of glucose uptake, positive regulation of glycogen anabolism, positive regulation of glycogen biosynthesis, positive regulation of glycogen formation, positive regulation of glycogen synthesis, positive regulation of lipid anabolism, positive regulation of lipid biosynthesis, positive regulation of lipid formation, positive regulation of lipid synthesis, positive regulation of lipogenesis, positive regulation of nitric oxide anabolism, positive regulation of nitric oxide biosynthesis, positive regulation of nitric oxide formation, positive regulation of nitric oxide synthesis, positive regulation of NOS activity, protein amino acid autophosphorylation, protein glutamyl kinase activity, protein homopolymerization, protein import into cell nucleus, translocation, protein kinase (phosphorylating) activity, protein kinase A activity, protein kinase p58 activity, protein phosphokinase activity, protein serine kinase activity, protein serine-threonine kinase activity, protein translocation during protein import into nucleus, protein translocation during protein transport from cytoplasm to nucleus, protein translocation during protein-nucleus import, protein transport from cytoplasm to nucleus, translocation, protein-aspartyl kinase activity, protein-cysteine kinase activity, protein-nucleus import, translocation, protein-serine kinase activity, Prp4 protein kinase activity, Raf kinase activity, Raf-1, regulation of neurite biosynthesis, regulation of neurite development, regulation of neurite formation, regulation of neurite growth, regulation of protein anabolism, regulation of protein biosynthesis, regulation of protein formation, regulation of protein synthesis, response to heat shock, response to UVA light stimulus, response to UV-A light stimulus, response to UVA radiation stimulus, response to UV-A radiation stimulus, ribosomal protein S6 kinase II activity, ribosomal S6 protein kinase activity, serine kinase activity, serine protein kinase activity, serine(threonine) protein kinase activity, serine/threonine protein kinase activity, serine-specific protein kinase activity, stimulation of cell growth, stimulation of fat cell differentiation, stimulation of glucose import, stimulation of glycogen biosynthetic process, stimulation of lipid biosynthetic process, stimulation of nitric oxide biosynthetic process, stimulation of nitric-oxide synthase activity, STK32, T cell co-stimulation, T lymphocyte costimulation, T-antigen kinase activity, T-cell costimulation, T-cell co-stimulation, threonine-specific protein kinase activity, T-lymphocyte costimulation, twitchin kinase activity, up regulation of cell growth, up regulation of fat cell differentiation, up regulation of glucose import, up regulation of glycogen biosynthetic process, up regulation of lipid biosynthetic process, up regulation of nitric oxide biosynthetic process, up regulation of nitric-oxide synthase activity, upregulation of cell growth, up-regulation of cell growth, upregulation of fat cell differentiation, up-regulation of fat cell differentiation, upregulation of glucose import, up-regulation of glucose import, upregulation of glycogen biosynthetic process, up-regulation of glycogen biosynthetic process, upregulation of lipid biosynthetic process, up-regulation of lipid biosynthetic process, upregulation of nitric oxide biosynthetic process, up-regulation of nitric oxide biosynthetic process, up-regulation of nitric-oxide synthase activity, upregulation of nitric-oxide synthase activity, Wee 1-like kinase activity, WEE1Hu, Wee-kinase activity
UniprotAccessions :
P31749
基因 :
AKT1
GeneID网址 :
www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=207
EntityFormats :
纯化
UNSPSC :
12352203
ProductForm :
Purified IgG - liquid
PriceDKK :
2337
PrimarySecondary :
Primary
PriceGBP :
244
PriceEUR :
314
PriceUSD :
314美元
PriceCHF :
368
PriceSEK :
3130
PriceNOK :
3110
更多信息或购买 :
公司信息
伯乐(Bio-Rad)公司
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
44-1865-852-700
公司总部: 英国
伯乐(Bio-Rad)公司是世界领先的抗体生产商之一。通过其原名为AbD Serotec公司的专业抗体业务团队,提供超过12,000种抗体及相关试剂,专注于免疫学、肿瘤、兽医研究及细胞生物学等领域。
抗体产品包括细胞凋亡试剂盒,自噬检测试剂,CD分子标记物,标签抗体,免疫学研究抗体,神经科学研究抗体和兽医应用试剂等。
伯乐(Bio-Rad)公司在英国拥有经ISO9001和ISO13485认证的生产厂房,同时在德国和美国均设有经ISO9001认证的厂房。
我们专业领域已扩展到传统和重组抗体制备及生产服务。我们的抗体定制服务仅需8周就能完成抗体制备并且成功率在90%以上。我们的体外重组抗体技术能够使得我们筛选制备针对具有挑战性的靶点的抗体,确保长期稳定供货,并能够提供抗体的相应基因序列。
伯乐(Bio-Rad)公司 致力于提供帮助您成功的抗体。我们专注于提供技术、产品及相关所有支持信息以协助您出色完成相关科学研究。